Jun 4, 2026 06:42AM
May 6, 2026 04:01PM
May 4, 2026 08:02AM
May 4, 2026 08:00AM
May 1, 2026 04:36PM
May 1, 2026 04:35PM
Apr 28, 2026 07:12PM Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
Apr 9, 2026 11:03AM
Apr 9, 2026 11:02AM
Apr 9, 2026 06:42AM
Apr 8, 2026 04:45PM
Apr 8, 2026 04:44PM
Mar 19, 2026 04:34PM
Mar 3, 2026 08:03AM FDA grants Vanda formal hearing on HETLIOZ jet lag application
Mar 3, 2026 08:01AM
Feb 25, 2026 07:19AM
Feb 25, 2026 07:18AM
Feb 23, 2026 06:36AM
Feb 23, 2026 05:19AM
Feb 20, 2026 05:59PM
Feb 20, 2026 05:59PM Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovat
Feb 11, 2026 04:01PM
Jan 8, 2026 07:01AM
Jan 8, 2026 07:00AM
Jan 5, 2026 06:41AM
Dec 31, 2025 04:25AM
Dec 30, 2025 06:13PM
Dec 30, 2025 06:13PM Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
Dec 17, 2025 07:30AM
Dec 15, 2025 07:01AM
Dec 15, 2025 07:00AM
Dec 4, 2025 04:22PM
Dec 4, 2025 04:21PM
Dec 1, 2025 06:35AM
Nov 28, 2025 07:00AM Vanda gets FDA extension for tradipitant motion sickness drug review
Nov 28, 2025 07:00AM
Nov 17, 2025 06:37PM
Oct 29, 2025 04:01PM
Oct 2, 2025 06:45AM
Oct 1, 2025 05:03PM
Oct 1, 2025 05:02PM
Sep 25, 2025 08:03AM Vanda publishes study showing HETLIOZ improved sleep in insomnia patients
Sep 25, 2025 08:00AM
Aug 28, 2025 07:00AM
Aug 28, 2025 07:00AM
Aug 21, 2025 04:40PM
Aug 21, 2025 04:40PM
Aug 21, 2025 06:36AM
Aug 18, 2025 07:01AM Federal appeals court overturns FDA denial of Vanda's jet lag drug
Aug 18, 2025 07:00AM

323,284 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All